Why the study?
Left ventricular overload during VA ECMO endangers myocardial recovery, prompting questions about the optimal unloading modality, benefits, potential risks, and timing.
Does left ventricular unloading improve myocardial recovery and mortality in patients on VA ECMO support?
Does left ventricular unloading improve myocardial recovery and mortality in patients on VA ECMO support?
Left ventricular unloading during VA ECMO support, such as with the Impella device, is a promising strategy to improve hemodynamics and potentially reduce cardiogenic shock mortality.
LV unloading in VA-ECMO remains hypothesis-generating; randomized trials needed before practice change.
Impressively increasing availability of the mechanical circulatory/cardiac support systems (MCS) worldwide, together with the deepening of the knowledge of critical care medical practitioners, have inevitably led to the discussion about further improvements of intensive care associated to MCS. An appealing topic of the left ventricle (LV) overload related to VA ECMO support endangering myocardial recovery is being widely discussed within the scientific community. Unloading of LV leads to the reduction of LV end-diastolic pressure, reduction of pressure in the left atrium and decrease of the LV thrombus formation risk. Consequently, better conditions for myocardial recovery, with comfortable filling pressures and better oxygen delivery/demand ratio are achieved. The combination of VA ECMO and Impella device, also called ECPELLA seems to be a promising strategy which may bring the improvement of CS mortality rates. The series of presented trials and meta-analyses clearly showed potential benefits of this strategy. However, the ongoing research has brought a series of new questions, as whether Impella itself is the only appropriate unloading modality, or any other approach to unload LV would be beneficial in the same way? Benefits and potential risks of LV unloading and its timing are being discussed in current review.
No takes yet. Share an insight, caveat, or question.
Šoltés et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: